Commercial ACOs May Find Footing Where CMS Slips
The commercial ACOs often aren't even called ACOs. They're called alliances, partnerships, affiliations or any number of other names. The Michigan Blues, for instance, calls its program 'organized systems of care.' And these commercial ACOs aren't limited to hospital and physician teams. They are configured to include:
- Health plans and physicians (Anthem Blue Cross and Individual Practice Association Medical Group of Santa Clara County in the San Francisco area or CIGNA and Piedmont Physicians Group in Atlanta)
- Health plans and hospitals (Aetna and Carillion Clinic in Roanoke or Humana and Norton Healthcare in Louisville)
- Physicians and physicians (VISTA Health System and Central Jersey Physician Network in Summit, N.J.)
- Hospital systems and hospital systems (Methodist Health System and Texas Health Resources in Dallas)
Minnesota's Mayo Clinic may not be interested in the CMS version of accountable care organizations, but it is making moves to strengthen and extend its hospital-physician integration model. In May it signed an agreement with Altru Health System in Grand Forks, N.D. Altru's hospital and clinics now have access to Mayo Clinic physicians, as well as to Mayo's disease management protocols, clinical trials, and clinical care guidelines.
While Mayo isn't slapping the ACO name on this arrangement, it certainly reflects efforts to improve care coordination across multiple systems and to provide better care to patients. Time will tell if this arrangement is cost-effective as well.
A few months ago I spoke with Steve Mansfield, president and CEO of Methodist Health System in Dallas.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- Defensive Medicine Still Prevalent Despite Tort Reform
- WellPoint Dominates Nearly Half of Markets, AMA Says
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening